Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
55.35B
Market cap55.35B
Price-Earnings ratio
21.57
Price-Earnings ratio21.57
Dividend yield
0.84%
Dividend yield0.84%
Average volume
1.58M
Average volume1.58M
High today
$288.52
High today$288.52
Low today
$281.00
Low today$281.00
Open price
$282.50
Open price$282.50
Volume
1.72M
Volume1.72M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

The current Cencora, Inc.(COR) stock price is $281.00, with a market capitalization of 55.35B. The stock trades at a price-to-earnings (P/E) ratio of 21.57 and offers a dividend yield of 0.84%.

On 2026-06-24, Cencora, Inc.(COR) stock moved within a range of $281.00 to $288.52. With shares now at $281.00, the stock is trading 0.0% above its intraday low and -2.6% below the session's peak.

Trading activity shows a volume of 1.72M, compared to an average daily volume of 1.58M.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

COR News

Simply Wall St 14h
Cencora Launches Nucleus Pilot And Names A New HR Chief

Cencora (NYSE:COR) has launched a multi site pilot of its enhanced Nucleus inventory management solution for specialty physician practices. The company also an...

Cencora Launches Nucleus Pilot And Names A New HR Chief
TipRanks 16h
Cencora price target raised to $285 from $280 at BofA

BofA analyst Allen Lutz raised the firm’s price target on Cencora (COR) to $285 from $280 and keeps a Neutral rating on the shares. At the firm’s Healthcare con...

TipRanks 2d
Cencora Insider Makes Bold Million-Dollar Move Into Company Stock

New insider activity at Cencora ( (COR) ) has taken place on June 22, 2026. TipRanks' Prime Week Sale - 70% Off Unlock powerful investing tools and data-driven...

Analyst ratings

78%

of 18 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.